Brazil / EMS Sales Soar; Irregularities in Indian Vaccine Deal; Personalised Medicine Challenges
The latest news from Brazilian pharma, including an investigation into the country’s deal with Indian lab Bharat…
Eli Lilly Brazil
Last updated: 01.06.2015
Address: Av. Morumbi, 8264 – Brooklin CEP 04703-002 – São Paulo, SP,Brazil
Tel: (11) 2144-6911
Company description
Eli Lilly and Company, Lilly or simply, as it is known that the pharmaceutical industry of North America, has 134 years of existence. The company, with global operations and one of the largest funds applied research and development, is today one of the largest biotech companies in the world and owns brands that have become synonymous with ancient relief for diseases such as Prozac and Zyprexa Cialis, and prefers to characterized as a company that sells innovation in physical and mental health through medications that are usually the pioneers and most advanced in their therapeutic classes.
In Brazil, the company participates in the construction of the pharmaceutical market 66 years ago, and is one of the most important industries in the country, one of the leaders in the areas of mental health, oncology and women’s health.
Products and services
Humulin, Humatrope, Humalog, Prozac, Gemzar , ReoPro, of Zyprexa, Evista, Xigris, of Cialis, Fort, Cymbalta and Byetta
Related
Brazil / Country's Largest Private Pharma Company Under Threat
Founded in 1950, EMS is one of the top two domestic pharma companies in Brazil. As a key player in the largest and…
Brazil / Pharma Market Outperforming LatAm, Vaccine Developments, Bolsonaro’s Political Standing
The Brazilian pharma market outperformed the Latin American average in Q1 of 2020 with a growth of 8.2 percent in…
Brazil / Top 5 Pharma Companies
Six of the top ten companies in the Brazilian pharma market are domestic.* Read on for an introduction to some of…
Brazil / Six Trends in the OTC Market Post-COVID-19
Panorama Faramceutico’s editorial team look at how the ongoing COVID-19 pandemic stands to affect Brazil’s over…
Clinical Trials / Chinese Sinovac Testing COVID-19 Vaccine in Brazil
In the race to develop the world’s first COVID-19 vaccine, Brazil – now one of the world’s…
LatAm / COVID-19 and the Brazilian Pharma Supply Chain
The editorial team at Panorama Farmaceutico explain how the COVID-19 pandemic and global trade flow stoppages are…
LatAm / What Can Brazil’s Pharma Industry Learn from India?
The editorial team at Panorama Farmaceutico explain why coordinated action is needed within Brazilian pharma to…
News Roundup / Brazilian Pharma April 2020
Below we highlight recent news in Brazilian pharma, including the impact of coronavirus as well as legal and…
Research Partnerships / Novartis Teams Up to Tackle Neglected Diseases in Brazil
Swiss pharma giant Novartis is teaming up with the Oswaldo Cruz Foundation (Fiocruz) in Brazil to conduct research…
Talent / Pharma Leadership Strategies for Brazil
Three seasoned pharma executives with a wealth of experience working in Brazil offer their insights on leadership…
Why Pharma Needs Transformational Leaders
Rodrigo Araujo of global organizational consulting firm Korn Ferry outlines what he sees as the leadership profile…
